Tag Archives: Genentech

Avastin Gets Green Light for Use in Kidney Cancer

By George Koroneos | Published: August 5, 2009
Image by Getty Images via Daylife Score another win for Genentech and its cancer treatment Avastin (bevacizumab). On Monday, the biotech giant, now owned entirely by Roche, announced that FDA has approved the drug for kidney cancer. Avastin blocks new blood vessels from forming and supplying tumors with the nutrients they need to grow and spread to [...]
Posted in News | Also tagged , , , , , , | Leave a comment

Roche and Genentech Seal the Deal
for $46.8 Billion

By George Koroneos | Published: March 12, 2009
After months and months of back and forth over the true value of Genentech, Roche finally got the good news it’s been looking for: Genentech’s board of directors, this morning, approved Roche’s latest offer of $46.8 billion ($95 per share) to acquire all shares of the biotech giant. Roche plans to keep the Genentech site in [...]
Posted in Biotech | Also tagged , , , , , | 1 Comment

Roche Unsweetens Genentech Pot and Takes it to the Shareholders

By George Koroneos | Published: January 30, 2009
Image by Getty Images via Daylife Roche wants Genentech and it’s sick of waiting for a deal. Six months after a special committee for the biotech firm’s board of directors rejected Roche’s offer of $43.7 billion or $89 a share, Roche has switched gears and dropped the offer to $86.50 per share and is taking negotiations to [...]
Posted in Deals | Also tagged , , , , | 1 Comment

JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"

By Audrey Erbes | Published: January 15, 2009
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events | Also tagged , , , , , , , , , , , | 1 Comment

What a Week! Roche and Genentech … and Mirus!?!

By Walter Armstrong | Published: July 25, 2008
The big news this week—and, for that matter, this year—is Roche’s offer to buy the 44 percent of Genentech that it doesn’t already own. The blogosphere is burning with all the predictable predictions, dire and otherwise, attendant on a big pharma takeover of a biotech. The phrase “killing the goose that’s been laying the golden [...]
Posted in Biotech, Deals, Gene therapy, R&D, Strategy, Technology | Also tagged , , , , | 1 Comment